 |
PDBsum entry 6gzt
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Microbiol
3:1377-1384
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation.
|
|
J.N.Pruneda,
R.J.Bastidas,
E.Bertsoulaki,
K.N.Swatek,
B.Santhanam,
M.J.Clague,
R.H.Valdivia,
S.Urbé,
D.Komander.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Pathogenic bacteria are armed with potent effector proteins that subvert host
signalling processes during infection1. The activities of bacterial
effectors and their associated roles within the host cell are often poorly
understood, particularly for Chlamydia trachomatis2, a World Health
Organization designated neglected disease pathogen. We identify and explain
remarkable dual Lys63-deubiquitinase (DUB) and Lys-acetyltransferase activities
in the Chlamydia effector ChlaDUB1. Crystal structures capturing intermediate
stages of each reaction reveal how the same catalytic centre of ChlaDUB1 can
facilitate such distinct processes, and enable the generation of mutations that
uncouple the two activities. Targeted Chlamydia mutant strains allow us to link
the DUB activity of ChlaDUB1 and the related, dedicated DUB ChlaDUB2 to
fragmentation of the host Golgi apparatus, a key process in Chlamydia infection
for which effectors have remained elusive. Our work illustrates the incredible
versatility of bacterial effector proteins, and provides important insights
towards understanding Chlamydia pathogenesis.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |